Molecular Insight Pharmaceuticals names new interim CEO
Mr Barlow will continue to serve out his term as a member of the company’s board of directors. The company had begun a search to identify a permanent

Mr Barlow will continue to serve out his term as a member of the company’s board of directors. The company had begun a search to identify a permanent

Under a five year collaborative agreement, Clarient and Definiens plan to develop and commercialize tools that will help to evaluate quantitative biomarkers that predict cancer treatment response to

Mr Ward is currently senior vice president and president of the cardiovascular sector at Medtronic. In this role, Mr Ward is responsible for all worldwide operations of the

Pursuant to the terms of the agreement, Morphotek will evaluate the liver-expression chemokine (LEC) technology in-house and have the right to exercise an option for a license. Should

The round was led by the Ed Bass Group of Fort Worth, Texas with The Halifax Group and CNF Investments a subsidiary of Clark Enterprises, as other major

The companies have a number of court actions pending involving cryoablation systems in the US and Canada and an International Trade Commission investigation each of which they have

Dr Laurencin will serve on both the audit and the compensation committees of the board of directors. Since August 2008, Dr Laurencin has been the vice president for

The agreement was entered into following the completion of due diligence and negotiation during an exclusivity period and provides for, among other things, a non-solicitation covenant on the

The data showed that in multiple well-established in vivo models of Type 2 diabetes, ARRY-403 was highly efficacious in controlling both fasting and non-fasting glucose, with rapid onset

Under the terms of the definitive merger agreement between Nuvelo, Arca and Dawn Acquisition Sub, a wholly owned subsidiary of Nuvelo, Dawn Acquisition Sub will be merged with